Source: GWASCAT

Gene Gene Full Name DSI g DPI g pLI Disease Type Score gda EL gda EI gda N. PMIDs N. SNPs gda First Ref. Last Ref.
Entrez Id: 9863
Gene Symbol: MAGI2
MAGI2 		membrane associated guanylate kinase, WW and PDZ domain containing 2 0.579 0.654 1.00
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 6103
Gene Symbol: RPGR
RPGR 		retinitis pigmentosa GTPase regulator 0.536 0.692 1.00
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2020 2020
Entrez Id: 604
Gene Symbol: BCL6
BCL6 		BCL6 transcription repressor 0.444 0.808 0.96
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 6014
Gene Symbol: RIT2
RIT2 		Ras like without CAAX 2 0.647 0.538 6.3E-04
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 57628
Gene Symbol: DPP10
DPP10 		dipeptidyl peptidase like 10 0.695 0.577 1.00
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 57466
Gene Symbol: SCAF4
SCAF4 		SR-related CTD associated factor 4 0.890 0.308 1.00
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 56894
Gene Symbol: AGPAT3
AGPAT3 		1-acylglycerol-3-phosphate O-acyltransferase 3 0.931 0.038 1.00
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 55576
Gene Symbol: STAB2
STAB2 		stabilin 2 0.743 0.423 9.2E-62
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 55297
Gene Symbol: CCDC91
CCDC91 		coiled-coil domain containing 91 0.729 0.423 3.8E-06
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 55199
Gene Symbol: FAM86C1
FAM86C1 		family with sequence similarity 86 member C1 0.931 0.077 5.6E-12
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 54898
Gene Symbol: ELOVL2
ELOVL2 		ELOVL fatty acid elongase 2 0.722 0.423 8.4E-10
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 53353
Gene Symbol: LRP1B
LRP1B 		LDL receptor related protein 1B 0.626 0.615 2.5E-06
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 6768
Gene Symbol: ST14
ST14 		suppression of tumorigenicity 14 0.514 0.769 0.56
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 7373
Gene Symbol: COL14A1
COL14A1 		collagen type XIV alpha 1 chain 0.674 0.615 1.4E-14
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 7392
Gene Symbol: USF2
USF2 		upstream transcription factor 2, c-fos interacting 0.626 0.654 0.99
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 9580
Gene Symbol: SOX13
SOX13 		SRY-box transcription factor 13 0.743 0.385 0.94
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 9420
Gene Symbol: CYP7B1
CYP7B1 		cytochrome P450 family 7 subfamily B member 1 0.563 0.692 3.3E-06
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 9215
Gene Symbol: LARGE1
LARGE1 		LARGE xylosyl- and glucuronyltransferase 1 0.526 0.654 0.99
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 9150
Gene Symbol: CTDP1
CTDP1 		CTD phosphatase subunit 1 0.641 0.577 6.0E-04
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 89797
Gene Symbol: NAV2
NAV2 		neuron navigator 2 0.722 0.385 1.00
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 864
Gene Symbol: RUNX3
RUNX3 		RUNX family transcription factor 3 0.459 0.731 0.84
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 8379
Gene Symbol: MAD1L1
MAD1L1 		mitotic arrest deficient 1 like 1 0.570 0.731 6.8E-16
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 8091
Gene Symbol: HMGA2
HMGA2 		high mobility group AT-hook 2 0.429 0.808 0.87
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 80206
Gene Symbol: FHOD3
FHOD3 		formin homology 2 domain containing 3 0.722 0.346 6.7E-02
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 79886
Gene Symbol: CAAP1
CAAP1 		caspase activity and apoptosis inhibitor 1 0.861 0.077 0.78
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019